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Long noncoding RNA AFAP1-AS1 acts as a
competing endogenous RNA of miR-423-5p
to facilitate nasopharyngeal carcinoma
metastasis through regulating the Rho/Rac
pathway
Yu Lian1,2,3†, Fang Xiong1,3†, Liting Yang1,3, Hao Bo3, Zhaojian Gong3, Yumin Wang3, Fang Wei1,3, Yanyan Tang2,5,
Xiayu Li4, Qianjin Liao2,5, Hui Wang5, Ming Zhou1,3, Bo Xiang1,3, Xu Wu2,6, Yong Li2,7, Xiaoling Li1,3, Xiang Chen1,
Guiyuan Li1,3, Can Guo1,3, Zhaoyang Zeng1,3* and Wei Xiong1,3*

Abstract
Background: Actin filament-associated protein 1 antisense RNA 1 (AFAP1-AS1), a long noncoding RNA, is significantly
highly expressed and associated with metastasis and poor prognosis in many cancers, including nasopharyngeal
carcinoma (NPC). In this study, we aim to identify the role of AFAP1-AS1 acting as an oncogenic lncRNA to promote
NPC metastasis.
Methods: The role of AFAP1-AS1, miR-423-5p, and FOSL2 in NPC metastasis was investigated in vitro and in vivo.
Bioinformatics analysis and luciferase activity assays were used to identify the interaction between AFAP1-AS1, miR-4235p, and FOSL2. Additionally, real-time PCR and western blotting were used to assess the function of AFAP1-AS1 acting
as an oncogenic lncRNA to promote NPC progression by regulating miR-423-5p and the downstream Rho/Rac pathway.
Results: In this study, we determined that AFAP1-AS1 functions as a competing endogenous RNA in NPC to regulate
the Rho/Rac pathway through miR-423-5p. These interactions can mediate the expression of RAB11B, LASP1, and FOSL2
and accelerate cell migration and invasion via the Rho/Rac signaling pathway or FOSL2. AFAP1-AS1 and FOSL2 could
competitively bind with miR-423-5p to regulate several molecules, including RAB11B and LASP1 of the Rho/Rac signaling
pathway. AFAP1-AS1 can also regulate the expression of LASP1, which was transcriptionally regulated by FOSL2, resulting
in increased migration and invasion of NPC cells via the Rho/Rac signaling pathway.
Conclusions: The observations in this study identify an important role for AFAP1-AS1 as a competing endogenous RNA
(ceRNA) in NPC pathogenesis and indicate that it may serve as a potential target for cancer diagnosis and treatment.
Keywords: Long noncoding RNA (lncRNA), AFAP1-AS1, miR-423-5p nasopharyngeal carcinoma (NPC), Competing
endogenous RNA (ceRNA)
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Background
Nasopharyngeal carcinoma (NPC) is a head and neck epithelial malignancy that occurs frequently in Southern
China [1–5]. Epstein-Barr virus exposure [6–15], diet, and
genetic factors [16] are implicated in its etiology. Although
radiotherapy is an effective treatment for NPC patients in
the early stages of the disease [17–20], the majority (75–
90%) of NPC cases are predisposed to metastasis at initial
diagnosis [21–24], which hampers efficacious treatment
and poses a high risk of disease recurrence. Enhancing
our understanding of the molecular mechanisms underlying NPC may promote the development of effective
metastasis-targeted therapy and improve the overall prognosis of patients with this disease.
Noncoding RNAs, including microRNAs (miRNAs),
long noncoding RNAs (lncRNAs) [25–33] and circular
RNAs (circRNAs) [34–37], have important roles in the
regulation of gene expression and are involved in the
development of a variety of human diseases, including
cancer. The lncRNA actin filament associated protein 1
antisense RNA 1 (AFAP1-AS1) maps to the antisense
DNA strand of AFAP1 and was first identified as highly
expressed in esophageal cancer [38]. AFAP1-AS1 is also
highly expressed in lung cancer and pancreas cancer, and
hepatocellular carcinoma [39–43]. We previously discovered that AFAP1-AS1 was significantly highly expressed in
NPC and associated with metastasis and poor prognosis
[44, 45]. Numerous cytoskeleton proteins, including proteins in the small GTPase Rho/Rac signaling pathway,
were identified and significantly regulated using the liquid
chromatography-tandem mass spectrometry (LC-MS/MS)
by siAFAP1-AS, suggesting that AFAP1-AS1 may regulate
NPC migration and invasion through this pathway; however, as a newly identified lncRNA, the mechanism by
which AFAP1-AS1 regulates the Rho/Rac signaling pathway remains unknown.
A new model of lncRNA involvement in gene regulation
has recently been proposed, called competing endogenous
RNA (ceRNA). This model proposes that lncRNAs and
mRNA transcripts affect one another by competitively
combining with miRNA response elements (MREs) to influence posttranscriptional regulation [46–48]. In this
way, lncRNAs bind with miRNAs to modulate regulation
of protein-coding gene expression and participate in the
regulation of cell behavior. These interactions between
mRNAs, miRNAs, and lncRNAs generate complex regulatory networks [49]. In this study, we found that AFAP1-AS1 acts as a ceRNA, competitively binding with
miR-423-5p and directly regulating RAB11B and LASP1
genes in the Rho/Rac pathway. AFAP1-AS1 can also regulate the expression of FOSL2 and its downstream genes by
competing with FOSL2 to bind miR-423-5p, resulting in
increased migration and invasion of NPC through the
Rho/Rac signaling pathway.
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Methods
Tissues and cell lines, chemicals, plasmids, and transfection

Thirty-two nasopharyngeal carcinoma samples and 13
nontumor nasopharyngeal epithelium tissues were obtained from patients. All samples were collected with the
consent of patients and the experiments were approved
by the ethics committee of Hunan Cancer Hospital,
Changsha, China. All fresh tissues were immersed in
RNALater (Ambion, Austin, TX, USA). The tissue samples were stored in a − 80 °C laboratory freezer. RNA
was isolated using TRIzol reagent (Invitrogen, Carlsbad,
CA, USA) according to the manufacturer’s protocol. The
NPC cell lines 5-8F and HNE2 were maintained in our
laboratory in RPMI 1640 medium supplemented with
10% fetal bovine serum (FBS; Invitrogen), penicillin
(100 U/ml, Sigma-Aldrich, St. Louis, MO, USA), and
streptomycin (100 mg/ml, Sigma-Aldrich). All cell lines
had been recently tested for mycoplasma contamination
and identified no cross-contaminated cell lines or mycoplasma contamination.
The synthetic miR-423-5p mimics and inhibitors were
supplied by Ruibo Co. (Guangzhou, China). siRNAs and
nontargeting scrambled control siRNAs were provided
by Invitrogen. The sequences of the AFAP1-AS1- and
FOSL2-targeting siRNAs are listed in Additional file 1:
Table S1. To construct the AFAP1-AS1 expression vector, the entire AFAP1-AS1 sequence was amplified by reverse transcription PCR (RT-PCR) and cloned into the
pcDNA3.1 vector. The open reading frame of FOSL2
(NM_005253) was cloned into the pENTR vector and
tagged with the C-terminal Flag and His peptide sequences was purchased from the Vigene Co. (Rockville,
MD, USA). Transfection of cells with plasmids, siRNAs,
and miRNAs was performed using Lipofectamine 3000
(Life Technologies, Grand Island, NY, USA) or HiPerFect (Qiagen, Hilden, Germany) transfection reagents,
according to the manufacturer’s instructions.
Online expression profiles analysis

NPC data sets and the corresponding clinical data were
downloaded from publicly available GEO databases.
These included 62 patients with NPC and 6 non-NPC
nasopharyngeal epithelial tissues from GSE73460 [50], 6
patients with NPC and 12 non-NPC epithelial tissues
from GSE32906 [50] and 122 patients with NPC with
survival status from GSE70970 [51].
Bioinformatics analysis, reporter plasmids, and luciferase
activity assays

Five software tools, RNAhybrid, RNA22, PITA, TargetScan, and RegRNA, were used for miRNA target prediction in this study. For miRNA target validation assays,
58 bp fragments of the AFAP1-AS1 sequence, or the
RAB11B, LASP1, RAC1, and FOSL2 3′-UTRs containing
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the wild-type (WT) and mutant (MT) binding sites for
miR-423-5p, were cloned into the pMIR-REPORT vector. The sequences of these synthetic oligonucleotides
are listed in Additional file 1: Table S1. Cells (5-8F and
HNE2) were cotransfected with pMIR-REPORT vectors
containing the WT sequences of the RAB11B, RAC1,
LASP1, or FOSL2 3′-UTRs or their corresponding mutants, along with the pRL-TK control vector and
miR-423-5p mimics, inhibitors, or negative control.
For the LASP1 promoter activity analysis, the Promoter
2.0 Prediction Server (http://www.cbs.dtu.dk/services/Pro
moter/) was used to predict potential AP1-binding sites in
the LASP1 promoter sequence. Three tandem the wild
type or mutant AP1-binding sites were inserted into
the TA-luciferase vector as synthetic oligonucleotides
encoding the wild type or mutant AP1-binding sites
(Additional file 1: Table S1).
The AP-1 cis-element reporter plasmid (the AP-1 reporter), which contains multiple conserved AP1-binding
sites for sensitive detection of AP-1 transcriptional activity, was purchased from Promega (pAP1-TA-luc; Promega, Fitchburg, WI, USA) to measure the AP-1
transcriptional activity. Plasmid transfection and luciferase assays were performed as described previously [52].
Cells were harvested 48 h posttransfection and assayed
using a Dual Luciferase Assay (Promega) according to
the manufacturer’s instructions. All transfection assays
were carried out in triplicate.
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Burlington, MA, USA). Blots were probed with antiGAPDH antibody (Cell Signaling Technology, Danvers,
MA, USA) as an endogenous control for equal loading.
Real-time PCR

Total RNA was isolated with TRIzol reagent (Invitrogen)
according to the manufacturer’s protocol. For miRNA
real-time PCR, cDNA was synthesized using the miScript system (Ruibo) according to the manufacturer’s instructions. miR-423-5p expression levels were measured
using a Ruibo miRNA primer assay (Ruibo) and a miDETECT Track miRNA qRT-PCR kit (Ruibo) according to
the manufacturer’s instructions. Data were normalized
to the small nuclear RNA RNU6B (U6 snRNA) expression level. For mRNAs and lncRNAs, real-time PCR expression analysis was carried out using a SYBR green
real-time PCR kit (Applied Biological Materials, Inc.,
Richmond, BC, Canada). Data were normalized to the
GAPDH expression level and further normalized to the
negative control, unless otherwise indicated. The
primers used for PCR are listed in Additional file 1:
Table S1. Fold changes in expression were calculated
using a relative quantification (2-ΔΔCt) method. All reactions were performed in triplicate and repeated in three
independent experiments.
in vivo nude mouse models

For wound healing assays, 5-8F and HNE2 cells were
seeded and grown to 90% confluence in 6-well culture
plates, and a 200 μl pipet tip was used to create a scratch
in the cell monolayer. Images were captured and measured with an ocular ruler to ensure that all wounds were
the same width at the beginning of each experiment.
For transwell assays, 5-8F and HNE2 cells in 200 μl
serum-free media were placed into upper transwell
chambers (8.0 μl pore size, BD Biosciences, Franklin
Lakes, NJ, USA) for invasion assays after transfection,
according to the manufacturer’s protocol. Invaded cells
were fixed and stained with methanol and 0.1% crystal
violet, counted under a microscope, and imaged. Independent experiments were carried out in triplicate.

Male BALB/C nude mice (5–6 weeks of age, 16–18 g)
were maintained in the experimental animal center of
Central South University in a pathogen-free facility. The
Institutional Animal Ethics Committee of Central South
University approved this animal study. Mice were divided into four groups, including the over-AFAP1-AS1,
negative control (NC), miR-423-5p, and over-FOSL2
groups. For metastasis assay, 2 × 106 5-8F cells in a volume of 200 ml with corresponding treatment were
tail-vein injected into five-week-old male BALB/c nude
mice which were randomly divided into four groups
(n = 10 for each group). 60 days later, the mice were killed,
and all the lungs are surgically removed and the number
of macroscopically visible pulmonary metastases nodules
per mouse was counted by two experienced pathologists.
Then, the lung tissues were fixed in 10% neutral
phosphate-buffered formalin, followed by HE staining.

Western blotting

Statistical analysis

Proteins were extracted and separated according to previously described methods. Membranes were incubated
overnight at 4 °C with primary anti-RHOA, anti-RHOC,
anti-RAC2, anti-RAB10, anti-RAB11B, anti-RAB11A,
anti-RHOGDI, anti-PFN1, anti-LASP1, or anti-FOSL2
antibodies (Proteintech, Wuhan, China). Blots were
visualized by exposure to X-ray films using an enhanced
chemiluminescence detection system (EMD Millipore,

All continuous variables are presented as the means ±
standard deviation (SD), and categorical data are expressed
as percentages. GraphPad Prism 5.0 (GraphPad Software,
Inc., La Jolla, CA, USA) was used for statistical analysis.
Student’s t-test was performed to assess significant
differences between two groups using p < 0.05 as the
significance threshold. Survival analysis was performed
by Kaplan-Meier curves and log-rank test for

Wound healing and transwell assays
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significance. A two-sided p-value of < 0.05 was considered statistically significant.
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Wound healing and transwell assays demonstrated that
overexpression of AFAP1-AS1 accelerated 5-8F and
HNE2 cell migration (Fig. 1b) and invasion (Fig. 1c).

Results
Overexpression of AFAP1-AS1 accelerates NPC cell migration
and invasion

We first confirmed the function of AFAP1-AS1 in NPC
cells migration and invasion. The overexpressing AFAP1-AS1 vector was constructed and transfected into the
NPC cell lines 5-8F and HNE2, and the expression of
AFAP1-AS1 was confirmed by real-time PCR (Fig. 1a).

AFAP1-AS1 physically interacts with miR-423-5p in NPC cells

To identify the mechanism of AFAP1-AS1 in NPC, we
used four programs (PITA, RNAhybrid, RNA22, and
RNAreg2.0) to predict potential lncRNA-miRNA interactions involving AFAP1-AS1. Among the results,
miR-423-5p was selected for further investigation, since

Fig. 1 Overexpression of AFAP1-AS1 stimulates NPC cells migration and invasion of in vitro. a. AFAP1-AS1 levels were detected by qRT-PCR in
5-8F and HNE2 cells after transfection with the pcDNA3.1-AFAP1-AS1 (AFAP1-AS1) vector and the empty pcDNA3.1 vector (NC). b. Wound healing
assays using 5-8F and HNE2 cells transfected with the pcDNA3.1-AFAP1-AS1 (AFAP1-AS1) or the pcDNA3.1 (NC) vectors. The relative ratio of wound
closure per field is shown on the right. Scale bars, 100 μm. *, p < 0.05; **, p < 0.01; ***, p < 0.001. c. Transwell analysis of 5-8F and HNE2 cells transfected
with the pcDNA3.1-AFAP1-AS1 (AFAP1-AS1) or the pcDNA3.1 vectors (NC). The relative ratio of invasive cells per field is shown on the right. For all
quantitative results, data are presented as the means and standard errors of the mean (± SEM) from three independent experiments. Scale bars,
100 μm. *, p < 0.05; **, p < 0.01; ***, p < 0.001
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it was the only interacting miRNA proposed by all these
four tools. Then, whether endogenous AFAP1-AS1 levels
were affected by miR-423-5p was examined through
transfection of miR-423-5p mimics or inhibitors into
5-8F and HNE2. Real-time PCR indicated that AFAP1-AS1 expression was reduced after transfection with
miR-423-5p mimics (Fig. 2a) and induced after transfection with miR-423-5p inhibitors in 5-8F and HNE2 cells
(Fig. 2b). These results indicated that AFAP1-AS1 was
negatively regulated by miR-423-5p in NPC cells. A total
of 2 binding sites for miR-423-5p were predicted in the
AFAP1-AS1 sequence. One binding site between 5021
and 5043 bp of AFAP1-AS1 (NR_026892, Fig. 2c) with
the lowest minimum free energy was selected, and its
wild-type (WT) and mutant (MT) sequences were
cloned into a pMIR-REPORT luciferase vector for luciferase activity assay. The result showed that transfection
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of miR-423-5p mimics into 5-8F and HNE2 cells reduced the luciferase activity generated by the wild-type
AFAP1-AS1 reporter (WT), but not that of the empty
vector or the reporter vector containing the mutant
miR-423-5p binding site (Fig. 2d). Moreover, transfection
with miR-423-5p inhibitors increased the luciferase activity of the wild type AFAP1-AS1 reporter (WT, Fig. 2e),
suggesting that miR-423-5p binds with AFAP1-AS1
through this site.

miR-423-5p is expressed at low levels in NPC and suppresses
cell migration and invasion

Based on the above findings, we screened online published miRNA datasets and found that miR-423-5p expression was low-expressed in NPC clinical samples
compared with nontumor nasopharyngeal epithelium

Fig. 2 miR-423-5p could bind with the AFAP1-AS1 sequence. a. The expression level of AFAP1-AS1 was reduced by miR-423-5p mimics compared
with negative controls (NC) in NPC cells transfected with miR-423-5p mimics or negative controls using the qRT-PCR method. b. The expression
level of AFAP1-AS1 was induced by miR-423-5p inhibitors (423-5p In) in 5-8F and HNE2 cells transfected with miR-423-5p mimics or negative controls.
c. Sequence alignment of human miR-423-5p within the AFAP1-AS1 sequence. The seed sequence of miR-423-5p matches the AFAP1-AS1 sequence.
Mutations within the AFAP1-AS1 sequence. AFAP1-AS1 in the mutant luciferase reporter constructs are as shown. d. The pMIR-reporter-AFAP1-AS1
vector was used for the luciferase assays. 5-8F and HNE2 cells were transfected with miR-423-5p mimics or control and luciferase reporters containing
the wide type or mutant AFAP1-AS1 sequence, as indicated. Firefly luciferase activity was normalized with Renilla luciferase activity. Relative luciferase
activities are presented. Data represent three independent experiments in triplicate. e. Luciferase activity was measured in 5-8F and HNE2 cells
cotransfected with miR-423-5p inhibitors, negative control, and the luciferase reporter constructs containing the wide type or mutant AFAP1-AS1
sequence, as indicated. *, p < 0.05; **, p < 0.01; ***, p < 0.001
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tissues in a gene expression profiling (GEP) dataset,
GSE73460 (Additional file 2: Figure S1a), and another
NPC GEP dataset, GSE32906 showed that the expression of miR-423-5p was tightly associated with the TNM
stages of NPC patients (Additional file 2: Figure S1b). In
the GSE70970 dataset, decreased miR-423-5p expression
was also associated with poor overall survival and poor
relapse-free survival (Additional file 2: Figure S1c) of
NPC patients. Then, the expression of AFAP1-AS1 and
miR-423-5p were examined in 32 NPC clinical samples
and 13 nontumor nasopharyngeal epithelium biopsies by
qRT-PCR. The results showed that miR-423-5p was
lowly expressed in NPC tissues compared with that in
nontumor nasopharyngeal epithelium tissues (Fig. 3a).
Conversely, AFAP1-AS1 was highly expressed in the
NPC tissues and tightly associated with the clinical
TNM stages, neck lymph node metastasis, and the T
stages of the patients (Fig. 3b). There was an inverse correlation between AFAP1-AS1 and miR-423-5p in the
NPC tissues (Fig. 3c).
Next, we measured the cell migration and invasion capacity of miR-423-5p in NPC cells. Wound healing and
transwell assays demonstrated that miR-423-5p overexpression using mimics inhibited cell migration and invasion
compared with those of negative control (Fig. 3d and e),
consistently with the functional effects of AFAP1-AS1
knockdown. Moreover, transfection with miR-423-5p
inhibitors had a consequence similar to the function
of AFAP1-AS1 overexpression in 5-8F and HNE2 cells
(Fig. 3f and g). Taken together, these results indicated that
AFAP1-AS1 might promote NPC cell migration and invasion via mutually regulated with miR-423-5p.

AFAP1-AS1 regulates the Rho/Rac signaling through
miR-423-5p

We previously used a proteomics strategy to determine that
AFAP1-AS1 regulates the expression of several small
GTPase family members, and modulates cancer cell metastasis via regulation of actin filament integrity [44]. However,
the mechanism by which AFAP1-AS1 regulates the GTPase
family members expression remains unknown. Since AFAP1-AS1 interacts with miR-423-5p, we hypothesized that
AFAP1-AS1 might act as a ceRNA to regulate the GTPase
family members through miR-423-5p.
We first confirmed that AFAP1-AS1 regulates the
small GTPase family members at the mRNA level. After
AFAP1-AS1 knockdown (siRNA) or overexpression in
5-8F and HNE2 cells, multiple members of the Rho/Rac
pathway were affected at the mRNA level, as determined
by real-time PCR (Fig. 4a), and the expression of these
molecules was also altered at the protein level, as revealed by western blotting (Additional file 2: Figure S2);
these results were consistent with those of our previous

Page 6 of 17

proteomics analysis [44]. Similar results were obtained
in 5-8F and HNE2 cells after transfection with
miR-423-5p mimics and inhibitors (Fig. 4b and c).
miR-423-5p regulated the expression of numerous molecules, including RAB10, RAB11A, RAC2, PFN1, RHOA,
RAC1, RHOC, LASP1, and RAB11B, in the Rho/Rac signaling pathway at both the mRNA (Fig. 4b) and protein
levels (Fig. 4c), suggesting that AFAP1-AS1 may regulate
the Rho/Rac signaling via miR-423-5p.
miR-423-5p regulates the Rho/Rac signaling by directly
targeting the 3′-UTRs of RAB11B and LASP1, but not that
of RAC1

As shown in Fig. 4, we found that the expression of
RAC1, RHOC, LASP1, and RAB11B was reduced by
miR-423-5p mimics and induced by miR-423-5p inhibitors at both the mRNA and protein levels. We next investigated whether miR-423-5p directly targeted these
molecules to regulate the Rho/Rac signaling pathway.
First, the 3′-UTR sequences of these genes were analyzed using the TargetScan software. Interestingly, the
3′-UTRs of RAC1, LASP1, and RAB11B contained numerous elements exactly complementary to the
miR-423-5p seed region. Next, the vectors containing
the wild type or mutant (mutations targeting the seed
miR-423-5p sequence) RAB11B, LASP1, and RAC1
3′-UTR sequences were constructed, and luciferase analysis showed that miR-423-5p mimics reduced luciferase
activity in 5-8F and HNE2 when transfected with vectors
containing the wild type RAB11B (Fig. 5a and b) and
LASP1 (Fig. 5c and d) 3′-UTR sequences, but not in
5-8F and HNE2 transfected with the wild type RAC1
3′-UTR (pMIR-WT) (Additional file 2: Figure S3). The
effect of miR-423-5p mimics on the luciferase activity of
the vectors containing the mutant RAB11B and LASP1
sequence was abolished in 5-8F and HNE2 cells (Fig. 5).
Transfection of miR-423-5p inhibitors in these cells had
the opposite effect on the luciferase activity of the
RAB11B and LASP1 3′-UTR reporter constructs (Fig. 5).
These results suggested that miR-423-5p regulated the
Rho/Rac signaling through direct binding the 3′-UTRs
of RAB11B and LASP1.
AFAP1-AS1 acts AS a ceRNA regulating FOSL2 expression
in NPC

The ceRNA hypothesis posits that specific lncRNA molecules function as sinks for pools of active miRNAs,
functionally liberating mRNA transcripts targeted by
certain miRNAs. Therefore, the expression of lncRNAs
that act as ceRNAs is usually positively correlated with
the expression levels of their affected mRNAs. To determine which mRNAs are regulated by AFAP1-AS1
through miR-423-5p via ceRNA, we first performed
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Fig. 3 The expression of miR-423-5p was negatively correlated with AFAP1-AS1 in NPC biopsies and inhibited NPC cell migration and invasion in vitro. a.
miR-423-5p was lowly expressed in 32 NPC tissues compared with 13 nontumor nasopharyngeal epithelial (NPE) tissues and correlated with the TNM
stages of NPC patients as indicated. b. AFAP1-AS1 was highly expressed in the same 32 NPC tissues compared with 13 nontumor tissues and tightly
correlated with the TNM stages, lymphoma metastasis, and the T stage of NPC patients, as indicated. c. The expression of miR-423-5p was tightly
negatively correlated with that of AFAP1-AS1 in the same 32 NPC tissues and 13 nontumor tissues as indicated. d. The invasion ability was measured in 58F and HNE2 cells after treatment with miR-423-5p mimics or negative control using wound healing assays. The relative ratio of wound closure per field is
shown at the bottom. Scale bars, 100 μm. e. Transwell assays were performed to measure the migration ability of miR-423-5p mimics in
5-8F and HNE2 cells after treatment with miR-423-5p mimics or negative control. The relative ratio of invasive cells per field is shown at the bottom. Scale
bars, 100 μm. f. Wound healing assays of 5-8F and HNE2 cells after treatment with miR-423-5p inhibitors or negative control. The relative ratio of wound
closure per field is shown to the bottom. Scale bars, 100 μm. g. Transwell assays were performed in 5-8F and HNE2 cells after treatment with miR-423-5p
inhibitors or negative control. The relative ratio of invasive cells per field is shown on the bottom. Scale bars, 100 μm. *, p < 0.05; **, p < 0.01; ***, p < 0.001

bioinformatics analysis to predict targets of miR-423-5p.
The NPC gene expression omnibus (GEO) datasets were
screened to identify mRNAs whose expression levels
were positively correlated with those of AFAP1-AS1. The
expression of FOSL2 was positively correlated with that
of AFAP1-AS1 [53] (Additional file 2: Figure S4).
Real-time PCR showed that FOSL2 was also overexpressed in those 32 NPC clinical samples compared with
nontumor nasopharyngeal epithelial samples and tightly
positively associated with the TNM stages, the T stages,
and lymphoma metastasis in patients with NPC (Fig. 6a),
positively correlated with the AFAP1-AS1 expression
(Fig. 6b) while negatively correlated with miR-423-5p
(Fig. 6c). The 3′-UTRs of FOSL2 were also predicted
with several potential binding sites complementary to
the miR-423-5p seed region (Fig. 6d). Transfection of
miR-423-5p mimics or inhibitors into 5-8F and HNE2
cells reduced or induced the mRNA and protein levels
of FOSL2, respectively (Fig. 6e). Luciferase assays also
showed that miR-423-5p mimics decreased the luciferase
activity of the wild type FOSL2 3′-UTR sequence
(pMIR-WT), while no effect was observed on the luciferase activity from vectors containing the mutant
miR-423-5p binding sites in 5-8F and HNE2 cells.
Transfection with miR-423-5p inhibitors had the opposite effect on the luciferase activity generated from the
FOSL2 3′-UTR (Fig. 6f ).
We hypothesized that, as a ceRNA, AFAP1-AS1
competed with FOSL2 to bind miR-423-5p; therefore,
we determined whether there was specific interplay
among AFAP1-AS1, miR-423-5p, and FOSL2. We
monitored both the mRNA and protein levels of
FOSL2 after AFAP1-AS1 overexpression and knockdown in 5-8F and HNE2 cells. As expected, AFAP1-AS1 overexpression increased both the mRNA and
protein levels of FOSL2, and siAFAP1-AS1 transfection reduced FOSL2 expression (Fig. 6g). Overall,
these results suggested that the role of AFAP1-AS1 in
modulating FOSL2 expression is mediated by its competitive binding with miR-423-5p in 5-8F and HNE2
cells. Together, these data indicated that AFAP1-AS1
functions as a ceRNA by competitively binding

miR-423-5p, thereby relieving the suppression of
FOSL2 expression by miR-423-5p in NPC.
FOSL2 accelerates NPC cell migration and invasion

To investigate the function of FOSL2 in NPC, a FOSL2
overexpression vector, including three Flag tags, was
constructed and its expression confirmed in 5-8F and
HNE2 cells (Fig. 7a). Wound healing and transwell assays demonstrated that overexpression of FOSL2 accelerated cell migration and invasion compared to those in
negative control (Fig. 7b). Moreover, FOSL2 knockdown
by siRNA (Fig. 7c) had the opposite effect (Fig. 7d).
Taken together, these results indicated that FOSL2 induces NPC cell migration and invasion.
FOSL2 activates transcription of LASP1 by binding its
promoter

FOSL2 is a member of the Fos family of transcription factors that heterodimerize with the Jun family members to
form the AP-1 complex, which is able to activate or suppress the expression of many genes involved in tumor
growth and progression [54]. As a transcription factor,
FOSL2 could modulate the expression of genes in the
Rho/Rac pathway. Therefore, we determined whether
FOSL2 could transcriptionally activate downstream genes
in the Rho/Rac signaling pathway. Bioinformatics analysis
indicated a potential FOSL2 binding site in the LASP1
promoter positioned at the − 322 to − 312 bp upstream of
the transcription start site (Fig. 8a). Next, luciferase reporter constructs containing the wild-type and mutant
LASP1 promoter sequences, including the potential
FOSL2 binding site, were constructed (Fig. 8a). An AP-1
luciferase vector, containing multiple conserved AP1binding sites for sensitive detection of the AP1 transcriptional activity, was used as a positive control. As shown in
Fig. 8b, FOSL2 activated transcription from only the
wild-type, but not the mutated LASP1 promoter in these
two cell lines. AFAP1-AS1 also participated in regulation
of the transcription activity of the AP-1 complex containing FOSL2. Overexpression of AFAP1-AS1 dramatically
increased and knockdown decreased the AP-1 transcriptional activity from a synthetic promoter including the
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Fig. 4 miR-423-5p regulates the small GTPase Rho/Rac signaling pathway through AFAP1-AS1. a. Many molecules in the Rho/Rac signaling
pathway, including RAB10, RAB11A, RAC2, PFN1, RHOA, RAC1, RHOC, LASP1 and RAB11B, were regulated at the mRNA level in 5-8F and HNE2 cells
by AFAP1-AS1 overexpression or knockdown. b. Many molecules in the Rho/Rac signaling pathway, including RAB10, RAB11A, RAC2, PFN1, RHOA,
RAC1, RHOC, LASP1 and RAB11B, were regulated at the mRNA level in 5-8F and HNE2 cells by overexpression or knockdown of miR-423-5p. c.
Expression of Rho/Rac proteins, including RAB10, RAB11A, RAC2, PFN1, RHOA, RAC1, RHOC, LASP1 and RAB11B, was examined at the protein level in
5-8F and HNE2 cells after overexpression or knockdown of miR-423-5p.*, p < 0.05; **, p < 0.01; ***, p < 0.001

AP-1 consensus-binding site (pAP1-TA-luc) (Fig. 8c).
FOSL2 knockdown also reduced LASP1 and AFAP1-AS1
expression (Fig. 8d). These results suggest that AFAP1-AS1 may regulate the Rho/Rac signaling pathway via
the AP-1 transcriptional complex through modulating
FOSL2 activity by competition with miR-423-5p.
The function of AFAP1-AS1, miR-423-5p, and FOSL2 in
NPC metastasis in vivo

The function of AFAP1-AS1, miR-423-5p, and FOSL2 in
metastasis was confirmed in nude mice. AFAP1-AS1-,

miR-423-5p-, and FOSL2-overexpressing 5-8F cell lines
were used in this study. The cells were injected into the
tail veins of nude mice; 5-8F-mock served as the control.
After 60 days, the mice were sacrificed, and the lungs,
livers, and lymph nodes were observed. Compared with
the control, metastasis to the lungs of 5-8F cells transfected with AFAP1-AS1 and FOSL2 significantly increased, while metastasis of 5-8F transfected cells with
miR-423-5p mimics were reduced (Fig. 9). These results
indicated that AFAP1-AS1 and FOSL2 enhanced NPC
metastasis and miR-423-5p reduced its metastasis.
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Fig. 5 miR-423-5p directly targets the 3′-UTRs of RAB11B and LASP1. a and c. Schematic diagrams of miR-423-5p binding sites in the 3′-UTRs of
the RAB11B (a) and LASP1 (c) mRNAs predicted using RNAhybrid software. b and d. Luciferase activity was measured in 5-8F and HNE2 cells after
cotransfection with miR-423-5p mimics or inhibitors and luciferase reporter constructs containing either wild-type or mutated miR-423-5p binding
sites from the RAB11B (b) or LASP1 (d) 3′-UTRs. miR-423-5p mimics attenuated luciferase activity from RAB11B-WT and LASP1-WT constructs, but
not from RAB11B-mutant and LASP1-mutant constructs. *, p < 0.05; **, p < 0.01; ***, p < 0.001

Discussion
A ceRNA hypothesis was proposed by Salmena et al. in
2011 [55]. The theory explains why mRNA, pseudogenes, lncRNA, and other molecules share miRNA response elements (MREs) and bind to identical miRNAs
competitively to affect cell status [56]. miRNAs and
MREs are two key elements in this hypothesis; miRNAs
bind not only to MREs in mRNAs but also to pseudogenes and lncRNAs, influencing mRNA and lncRNA expression levels posttranscriptionally. For example, the
tumor suppressor gene phosphatase and tensin homolog
(PTEN), a negative regulator of the oncogenic phosphoinositide 3-kinase/Akt signaling pathway, provides the

best evidence for disease-associated ceRNAs [57]. PTEN
pseudogene 1 (PTENP1) can increase PTEN expression
by binding to several miRNAs to suppress proliferation
of cancer cells [58, 59]. Conversely, when PTENP1 is
downregulated, more miRNAs are available to inhibit
PTEN expression, facilitating tumor growth. Both PTEN
and PTENP1 are controlled by ceRNA circuitry in many
cancers [60]. LncRNAs interact with miRNAs and
mRNAs as components of the cellular RNA language,
which comprises a complex, finely controlled network.
AFAP1-AS1 is highly expressed and tightly associated
with tumor progression in many cancers including
NPC [43]. We previously showed that AFAP1-AS1 was
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Fig. 6 AFAP1-AS1 acts as a ceRNA to regulate FOSL2 gene expression through miR-423-5p. a. The expression of FOSL2 and its correlation with the
TNM stages, lymphoma metastasis, and T stages in the same 32 NPC tissues and 13 nontumor tissues as indicated. b. The expression of FOSL2 was
tightly positively correlated with that of AFAP1-AS1 in 32 NPC tissues and 13 nontumor tissues as indicated. c. The expression of FOSL2 was tightly
negatively correlated with that of miR-423-5p in 32 NPC tissues and 13 nontumor tissues as indicated. d. Prediction of miR-423-5p binding sites in the
FOSL2 transcript. The red nucleotides are complementary to the miR-423-5p seed sequences. e. The expression of FOSL2 was regulated by miR-423-5p
at the mRNA and protein levels after transfection of miR-423-5p mimics, miR-423-5p inhibitors, or negative control in 5-8F and HNE2 cells. f. Luciferase
activity was measured in 5-8F and HNE2 cells cotransfected with miR-423-5p inhibitors, miR-423-5p mimics, or negative control, and luciferase reporters
containing WT or MT FOSL2 sequences, as indicated. g. The expression of FOSL2 was examined at the mRNA and protein levels in 5-8F and HNE2 cells
after transfection with AFAP1-AS1 overexpression vector, or siAFAP1-AS1

associated with poor prognosis in NPC and it promoted
cell migration and invasion via regulation of actin filament integrity and the Rho/Rac signaling [44]. In this
study, we explored the detailed molecular mechanism
of AFAP1-AS1 as a ceRNA in regulation of NPC cell
migration and invasion. We hypothesized that AFAP1-AS1 may act as a ceRNA to regulate the Rho/Rac
pathway; therefore, we employed bioinformatics
methods to predict potential miRNAs regulated by
AFAP1-AS1. miR-423-5p was the only miRNA predicted by all four tools used for these analyses and had
the lowest minimum free energy, suggesting that AFAP1-AS1 is likely a direct target of miR-423-5p. Many reports have identified miR-423-5p as an oncogene in
various cancers, including gastric cancer and hepatocellular carcinoma [61, 62]. In this study, we found that
miR-423-5p was low-expressed in NPC and its expression was negatively correlated with the clinical TNM
stages in NPC tumors. Overexpression of miR-423-5p
inhibited NPC cells migration and invasion, and inhibition of miR-423-5p produced the opposite phenotype.
The function of miR423-5p had an opposite effect to
those of AFAP1-AS1 on migration and invasion. Luciferase assays confirmed that miR-423-5p regulated the
3’-UTR of AFAP1-AS1. These results suggested that
AFAP1-AS1 may regulate downstream genes through
binding of miR-423-5p, and that miR-423-5p may have a
role as a tumor suppressor gene through its effects on different downstream genes in NPC.
We previously determined by the proteomic analysis
that expression levels of at least 209 proteins were significantly altered after AFAP1-AS1 knockdown in NPC
cells. Among these, the expression levels of many proteins involved in regulation of cytoskeletal dynamics
were confirmed as significantly altered using liquid
chromatography-tandem mass spectrometry (LC-MS/
MS) after AFAP1-AS1 knockdown, including those in
the small GTPase Rho/Rac signaling pathway: RAB10,
RAB11A, RAC2, PFN1, RHOA, RAC1, RHOC, LASP1,
and RAB11B [44]. The Rho/Rac signaling pathway is a
well-established regulator of the actin cytoskeleton, as
highlighted by the RAC1 dependence of membrane ruffling and RHOA-induced stress-fiber formation [63]. In
this study, we focused on the role of AFAP1-AS1 as a

noncoding RNA in regulation of the expression of these
proteins. We investigated whether AFAP1-AS1 acted as
a ceRNA through miR-423-5p to regulate the Rho/Rac
pathway. miR-423-5p inhibited the expression of RAC1,
RHOC, LASP1, and RAB11B and increased that of other
molecules, including RAB10, RAB11A, RAC2, PFN1, and
RHOA, consistently with the results after AFAP1-AS1 inhibition or overexpression [26]. These results implied
that AFAP1-AS1 regulated the Rho/Rac signaling pathway through miR-423-5p. As a microRNA, miR-423-5p
may directly regulate expression or translation of its target genes; therefore, we first examined whether some
molecules including RAC1, RAB11B, RHOC, and LASP1
in the Rho/Rac pathway were direct target genes of
miR-423-5p, since their expression levels were reduced
by the specific miR-423-5p mimics. Bioinformatics analysis predicted the RAB11B and LASP1 genes as targets
of miR-423-5p. Further experiments confirmed that
miR-423-5p directly targeted these two genes and that
AFAP1-AS1 acted as a ceRNA of RAB11B and LASP1,
regulating their expression by competitively binding
miR-423-5p, thus affecting the migration and invasion of
NPC. As we know, LASP1 is an actin-binding phosphoprotein that is overexpressed in several cancers [64–66]
and it is a cAMP- and cGMP-dependent signaling protein which binds to the actin cytoskeleton at extensions
of the cell membrane [67, 68]. RAB11B belongs to the
Rab family and regulates exocytotic and endocytotic
pathways [69]. Our experiments confirmed the hypothesis that AFAP1-AS1 acts as a ceRNA to regulate the expression of key genes, such as LASP1 and RAB11B, by
competitively binding miR-423-5p, resulting in dysregulation of the Rho/Rac1 signaling pathway and migration
and invasion of human NPC cells [70–72].
The expression of RAB10, RAB11A, RAC2, PFN1, and
RHOA were upregulated in 5-8F and HNE2 cells transfected with miR-423-5p mimics, which is consistent with
the results of experiments using siAFAP1-AS1 and suggests that AFAP1-AS1 and miR-423-5p are tightly associated with the Rho/Rac signaling pathway. miR-423-5p
may also indirectly regulate the expression of these proteins through its effects on other molecules. To identify
other direct targets of miR-423-5p, we screened genes
whose expression levels were highly correlated with
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Fig. 7 Functional analysis of FOSL2 in NPC cells. a. FOSL2 mRNA and protein levels were detected in 5-8F and HNE2 cells after transfection with
the FOSL2 overexpression vector (FOSL2) or the empty vector (NC) by qRT-PCR and western blotting. b. Wound healing and transwell assays of
5-8F and HNE2 cells were conducted after transfection with pENTR-FOSL2 or pENTR empty vector. The relative ratio of wound closure per field is
shown on the right. Scale bars, 100 μm. c. The expression of FOSL2 was examined at the mRNA and protein levels by qRT-PCR and western blotting in
5-8F and HNE2 cells after transfection with siFOSL2 or scrambled negative control siRNA. d. Wound healing and transwell assays were performed in
5-8F and HNE2 cells after treatment with siFOSL2 or scrambled siRNA control. The relative ratio of invasive cells per field is shown on the right. Scale
bars, 100 μm. *, p < 0.05; **, p < 0.01; ***, p < 0.001
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Fig. 8 FOSL2 modulates the transcription of LASP1 through binding its promoter. a. Prediction of potential FOSL2 binding sites in the LASP1
promoter. The nucleotides that are consensus FOSL2 binding sequences (WT) and mutated sequences (MT) are indicated. b. The luciferase activity
of the LASP1 promoter and the AP-1 transcription factor was measured in 5-8F and HNE2 cells cotransfected with the FOSL2 overexpression vector or
siFOSL2 and luciferase reporters containing the AP-1 luciferase plasmid (pAP1), or the WT or MT LASP1 promoter, as indicated. Overexpression of FOSL2
significantly induced the LASP1 and AP-1 transcription activity. *p < 0.05, **p < 0.01, compared with normal control (NC) group. c. The AP-1
transcription activity was examined through transfection of the AFAP1-AS1 overexpression vector or siAFAP1-AS1 and the AP-1 reporter plasmid
containing the AP-1 consensus sequence. AP-1 transcriptional activity was induced through overexpressing AFAP1-AS1 or reduced after knockdown
of AFAP1-AS1. d. The expression of LASP1 and AFAP1-AS1 was regulated by FOSL2 after knockdown or overexpression of FOSL2

those of AFAP1-AS1 in NPC tissues based on the results
of previous microarray analyses and the ceRNA theory.
FOSL2, a member of the Fos family [73], was analyzed
using various prediction tools and found to contain several potential miR-423-5p binding sites in its 3′-UTR,
while the expression of AFAP1-AS1 and FOSL2 was significantly correlated in NPC GEO datasets [53]. FOSL2
is a member of AP-1 transcription factor complexes.
FOS and Jun protein family members can form homo- or
heterodimers and bind to the promoters of specific genes
to promote or inhibit their transcription in combination
with other transcription and regulatory factors. In this
study, we found that FOSL2 could regulate the LASP1
transcription by binding its promoter, suggesting that
AFAP1-AS1 acts as a ceRNA in regulation of FOSL2 and
the AP-1 transcription factor activation, thereby affecting
the expression of small GTPase molecules. Whether

AFAP1-AS1 also regulates the expression of other downstream genes through FOSL2 is worthy of further
investigation.
In this study, we confirmed that AFAP1-AS1 functions
as a ceRNA by adsorption of miR-423-5p and verified that
LASP1, RAB11B, and FOSL2 are downstream target genes
of miR-423-5p (Additional file 2: Figure S5). However,
miRNAs can target multiple genes, and there may be
other protein-encoding genes regulated by miR-423-5p
among the 209 proteins regulated by AFAP1-AS1 in NPC
cells using our previous proteomic approach; this is also
worthy of further investigation.

Conclusions
AFAP1-AS1 may regulate a complex and sophisticated
gene network through miR-423-5p as a ceRNA.
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tightly associated with the TNM stage of NPC tumors in the GSE32906
miRNA array. N, n = 6; I-II, n = 4; III, n = 4; IV, n = 4; N vs IV, p = 0.02; N vs III,
p = 0.04. c. Kaplan-Meier curve analysis of overall survival (OS) and relapsefree survival (RFS) of patients with low and high miR-423-5p expression
using data from the GSE70970 dataset. HR, hazard ratio. Figure S2. Expression of some Rho/Rac proteins, such as RAB10, RAB11A, RAC2, PFN1, RHOA,
RAC1, RHOC, LASP1 and RAB11B, was examined in 5-8F and HNE2 cells after
overexpression of AFAP1-AS1. Figure S3. miR-423-5p could not target the
3′-UTR of RAC1. a. The schematic model showing the putative binding sites
for miR-423-5p on 3′-untranslated regions (3′-UTR) of RAC1. b. Luciferase
activities were measured in 5-8F and HNE2 cells cotransfected with
miR-423-5p mimics, miR-423-5p inhibitors, or negative control, and the
luciferase reporters containing the WT or MT RAC1 3′-UTR. Transfection
of miR-423-5p mimics or inhibitors into 5-8F and HNE2 cells could not
significantly reduce or increase the luciferase activity generated by the
WT and the reporter vector containing the MT miR-423-5p binding site
of the RAC1 3′-UTR reporter (pMIR-WT). Figure S4. Pearson correlation
analysis was performed to evaluate the correlation between the expression
of FOSL2 and AFAP1-AS1 using the GSE64634 dataset (r = 0.5256, p = 0.0365).
Figure S5. A schematic model of AFAP1-AS1 competitively binding
miR-423-5p to upregulate RAB11B or LASP1 or FOSL2 transcription factor
signaling and accelerate NPC metastasis. (PDF 199 kb)
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Fig. 9 The function of AFAP1-AS1, 423-5p, and FOSL2 in the metastasis
of nasopharyngeal carcinoma 5-8F cells in vivo. a. Forty nude mice
were randomly divided into 4 groups with 10 mice per group. Three
experimental groups were injected with 5-8F cells transfected with the
AFAP1-AS1 overexpression plasmid, miR-423-5p mimics, or the FOSL2
overexpression plasmid through the tail veins, and the control group
was injected with 5-8F mock cells (NC). After 8 weeks, the nude mice
were sacrificed, and the metastatic tumors were observed (upper
panel). Representative lung tissue and metastatic nodes are indicated
by arrows (lower panel). b. Metastatic nodes per lung in each group

Identification of the ceRNA network involving AFAP1-AS1 may contribute to a better understanding of NPC
carcinogenesis and tumor progression. Our data also suggest that targeting AFAP1-AS1 and/or miR-423-5p have
potential as a new therapeutic strategy and that these molecules are potential biomarkers in NPC.
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